Teleflex (NYSE:TFX) Trading Down 7% – What’s Next?

Teleflex Incorporated (NYSE:TFX) dropped 7% during mid-day trading on Thursday . The stock traded as low as $125.18 and last traded at $123.9770. Approximately 173,065 shares were traded during mid-day trading, a decline of 82% from the average daily volume of 963,433 shares. The stock had previously closed at $133.30.

Analysts Set New Price Targets

TFX has been the topic of several research reports. Zacks Research raised shares of Teleflex from a “strong sell” rating to a “hold” rating in a research report on Tuesday. Royal Bank Of Canada reissued a “sector perform” rating on shares of Teleflex in a research report on Tuesday, April 14th. Bank of America raised shares of Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 price target on the stock in a research report on Monday, April 13th. Wells Fargo & Company boosted their price target on shares of Teleflex from $116.00 to $130.00 and gave the company an “equal weight” rating in a research report on Friday, February 27th. Finally, Raymond James Financial raised shares of Teleflex from a “market perform” rating to an “outperform” rating and set a $128.00 price target on the stock in a research report on Friday, March 27th. Three research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $138.50.

Teleflex Price Performance

The business’s 50-day moving average price is $118.74 and its 200 day moving average price is $116.78. The company has a quick ratio of 2.01, a current ratio of 2.54 and a debt-to-equity ratio of 0.81. The company has a market capitalization of $5.40 billion, a P/E ratio of -5.94, a price-to-earnings-growth ratio of 0.89 and a beta of 0.82.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, February 26th. The medical technology company reported $1.93 EPS for the quarter, missing analysts’ consensus estimates of $3.73 by ($1.80). Teleflex had a negative net margin of 30.56% and a positive return on equity of 14.30%. The firm had revenue of $569.00 million during the quarter, compared to the consensus estimate of $912.57 million. During the same quarter last year, the business posted $3.89 earnings per share. Teleflex’s revenue was down 28.5% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Analysts anticipate that Teleflex Incorporated will post 6.77 EPS for the current fiscal year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 31st. Stockholders of record on Friday, March 6th were given a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date was Friday, March 6th. Teleflex’s dividend payout ratio (DPR) is -6.62%.

Hedge Funds Weigh In On Teleflex

A number of large investors have recently modified their holdings of TFX. MassMutual Private Wealth & Trust FSB boosted its position in shares of Teleflex by 57.9% in the third quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock valued at $26,000 after acquiring an additional 77 shares during the period. Banque Cantonale Vaudoise boosted its position in shares of Teleflex by 82.5% in the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after acquiring an additional 113 shares during the period. Hantz Financial Services Inc. boosted its position in shares of Teleflex by 248.8% in the third quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock valued at $34,000 after acquiring an additional 199 shares during the period. Mirae Asset Global Investments Co. Ltd. bought a new stake in Teleflex during the third quarter valued at approximately $35,000. Finally, V Square Quantitative Management LLC bought a new stake in Teleflex during the fourth quarter valued at approximately $37,000. 95.62% of the stock is currently owned by institutional investors.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.